3 beaten-down ASX 200 stocks tipped to rocket over 100% higher 

Find out what the experts expect from these shares in 2026.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The S&P/ASX 200 Index (ASX: XJO) reached a new all-time high on Wednesday. And while many big achievers helped drive the index to new highs, some beaten-down shares have moved in the opposite direction.

But not all of them will continue spiralling.

Here are three ASX 200 stocks that are expected to stage a turnaround this year. And some could climb as high as 100%, or even more.

Three businesspeople leap high with the CBD in the background.

Image source: Getty Images

Xero Ltd (ASX: XRO)

Xero shares were in the green on Wednesday afternoon, but the stock is still down nearly 60% over the past 12 months. 

The cloud-based accounting software company was caught up in the sector-wide tech sell-off and AI-related nervousness late last year (and into early 2026). This, combined with investor worry about the company's Melio acquisition, and potentially overvalued share price, saw many sell up. 

But Xero's business model, which is often referred to as "sticky",  has recurring revenue, global exposure, and profitability. It's actively expanding its presence and its product suite, too. 

I think there's a chance that the ASX 200 stock could double in value in 2026. Some analysts think it could storm even higher. Data shows the majority (12 out of 13) have a buy or strong buy rating on the stock with a maximum target price of $229.89 a piece. That implies a huge potential 204.98% upside at the time of writing.

Pro Medicus Ltd (ASX: PME)

Pro Medicus shares enjoyed a reprieve on Wednesday and closed in the green for the day. It comes off the back of a long string of declines due to similar sector-wide headwinds, which affected Xero stock.

Three of the company's directors have increased their existing stake by purchasing additional Pro Medicus shares, which raises a green flag for other investors. 

Out of 14 analysts, nine have a buy or strong buy rating on the stock. The average target price is $220.75, which implies a 91.57% upside at the time of writing. However, some think it could soar even higher to $300 a piece. That represents a potential 160.35% upside for Pro Medicus shares.

WiseTech Global Ltd (ASX: WTC)

WiseTech shares jumped over 10% after the company posted its half-year results on Wednesday morning. From an AFP and ASIC raise to a boardroom fallout, the logistics software company has sent WiseTech shares crashing over the past 8 months.

But investors are happy with the latest results announcement, suggesting that investor sentiment could finally be turning a corner for the beaten-down ASX 200 stock.

Most analysts already had a strong buy rating on the tech stock, with a maximum target price of $167.64 over the next 12 months. Even after Wednesday's rally, that implies a huge 253.23% upside for investors at the time of writing.

Motley Fool contributor Samantha Menzies has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended WiseTech Global and Xero. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has positions in and has recommended WiseTech Global and Xero. The Motley Fool Australia has recommended Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

flying asx share price represented by man flying remote control drone
Growth Shares

Why are DroneShield shares suddenly rising again?

A guidance miss, then a sharp bounce. What changed?

Read more »

Person handing out $50 notes, symbolising ex-dividend date.
Growth Shares

Where I'd invest $25,000 into ASX shares in August

I outline why these shares could be top picks for investors this month and for years to come.

Read more »

A female soldier flies a drone using hand-held controls.
Growth Shares

ASX defence shares have been the trade of the decade. Is it too late to join the party?

Order books are growing. Share prices aren't.

Read more »

Group of people cheer around tablets in office
Growth Shares

3 growing ASX 300 shares I'd buy with $5,000

All three businesses have something to prove, but strong execution could make them considerably larger over time.

Read more »

Excited couple celebrating success while looking at smartphone.
Growth Shares

5 ASX shares I'd buy with $5,000 in August

I think these ASX 200 shares are now trading below fair value.

Read more »

A boy stands in front of two similar but slightly different doors, scratching his head as to which one to choose.
Growth Shares

Looking for both growth and income? This ASX share is the perfect choice

You don't always have to choose between growth and income.

Read more »

Three business people stand on platforms in the desert and look out through telescopes.
Growth Shares

2 top ASX shares to buy and hold for the next decade

These ASX shares have a lot to offer long-term investors.

Read more »

Woman using a pen on a digital stock market chart in an office.
Growth Shares

My top ASX 200 stock picks for August

I think the next decade could give these market leaders plenty of time to deepen their advantages.

Read more »